Despite what you might expect from the name, chronic anaplasmosis is not a recognized clinical entity in humans based on current medical evidence. Human granulocytic anaplasmosis (HGA), caused by the tick-borne bacterium Anaplasma phagocytophilum, typically runs a self-limited course, and there is little evidence to support the idea that the bacterium establishes long-term infection in people.1PubMed Central. Human granulocytic anaplasmosis Yet the question persists, partly because the organism does cause chronic infection in animals, partly because some patients report lingering symptoms after treatment, and partly because tick-borne infections in general are dogged by controversy over what “chronic” really means.
What Acute Anaplasmosis Actually Looks Like
The typical case of HGA begins one to two weeks after a tick bite. Symptoms are nonspecific enough that many patients are initially told they have a mild virus: fever, headache, muscle aches, fatigue, and sometimes chills or nausea. Blood work often reveals low white blood cell counts, low platelet counts, and elevated liver enzymes, which can tip off a clinician thinking about tick exposure. Most people recover fully with a standard course of doxycycline, and many who are never treated also recover on their own.
That said, the infection is not always benign. Roughly 3% of patients develop life-threatening complications, and close to 1% die.1PubMed Central. Human granulocytic anaplasmosis When severe disease occurs, it tends to escalate quickly, and the complications are driven more by the body’s inflammatory response than by the bacteria directly destroying tissue.
The Gap Between Animal Evidence and Human Disease
One reason “chronic anaplasmosis” keeps coming up is that the bacterium genuinely does persist for long periods in animals. In naturally infected wild rodents, A. phagocytophilum has been detected for more than three months, with some animals carrying the bacterium for over a year.2PubMed. Long-term persistence of Anaplasma phagocytophilum and Ehrlichia muris in wild rodents In cattle and other ruminants, the related species A. marginale causes lifelong infection, and A. phagocytophilum itself can persist in these animals for years.3Comparative Immunology, Microbiology and Infectious Diseases. Adaptive immunity to Anaplasma pathogens and immune dysregulation: Implications for bacterial persistence
The jump from those findings to human chronic infection is not straightforward, though. Rodents and ruminants serve as reservoir hosts; the bacterium has evolved alongside their immune systems for millennia. Humans are incidental hosts, meaning we get infected by accident when a tick feeds on us after feeding on an infected animal. The human immune system handles A. phagocytophilum differently, and so far researchers have not demonstrated persistent carriage in people the way they have in mice or cattle. The evidence reviewed in clinical literature finds little support for a role of A. phagocytophilum in chronic human illness.1PubMed Central. Human granulocytic anaplasmosis
Why Symptoms Can Linger After the Infection Clears
If the bacterium doesn’t persist, why do some patients feel lousy for weeks or months after treatment? The answer appears to be inflammatory. During active HGA, patients show dramatically elevated levels of pro-inflammatory signaling molecules. One study found that interferon-gamma, a key immune signal, was almost eight times higher in anaplasmosis patients than in healthy controls, and several other inflammatory markers were more than doubled.4PLoS ONE. Pro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis That inflammatory surge is what causes fever, muscle pain, and fatigue in the first place. It also correlates with symptom severity.
Research in animal models has shown that the host’s own immune activation, rather than the bacterium itself, is a major contributor to organ damage. In mouse studies, key immune pathways were found to drive hepatic (liver) injury more than the bacterium directly.5PubMed Central. Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury Once a strong inflammatory response has been triggered, the aftereffects can take time to resolve even after the infection itself has been cleared by antibiotics or the immune system. This is a common pattern across infectious diseases, and it does not require persistent bacteria to explain prolonged fatigue or malaise.
How the Bacterium Evades Immune Cells
A. phagocytophilum has an unusual trick: it infects the very white blood cells (neutrophils) that are supposed to kill it. Normally, when a neutrophil engulfs a bacterium, it generates a burst of toxic molecules and then self-destructs in a programmed sequence. A. phagocytophilum short-circuits both steps. It blocks the toxic burst and prevents the neutrophil from triggering its normal self-destruct program, effectively turning its predator into a shelter.6PubMed. Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils
This is part of what makes the bacterium so effective during acute infection. But neutrophils are short-lived cells regardless, surviving only a day or two in circulation. That built-in turnover limits how long the bacterium can hide inside any individual cell. In reservoir animals, the organism seems to have additional strategies for cycling between cell types and staying ahead of the immune response indefinitely. In humans, the immune system appears to win that arms race relatively quickly, which aligns with the clinical observation that most people clear the infection within days to weeks.
When Severe Complications Develop
The cases that make anaplasmosis genuinely dangerous tend to involve multi-organ problems. A systematic review of the literature found that acute kidney injury was the most commonly reported complication, sometimes severe enough to require temporary dialysis.7PLOS Neglected Tropical Diseases. Human granulocytotropic anaplasmosis—A systematic review and analysis of the literature Most patients with kidney involvement recovered fully after treatment, but the acute phase could be harrowing.
Patients who are immunocompromised face the greatest risk. A striking case report documented a patient who had undergone spleen removal decades earlier and developed multi-organ failure from anaplasmosis, including pneumonia, respiratory distress, rhabdomyolysis, kidney injury, atrial fibrillation, and possible inflammation of the heart muscle.8PubMed Central. Severe Anaplasmosis with Multi-Organ Failure in a Patient with Splenectomy: A Case Report The spleen is a critical organ for filtering blood-borne pathogens, so its absence allowed the infection to escalate. Older adults, people on immunosuppressive medications, and organ transplant recipients are similarly at elevated risk of severe outcomes.
The Coinfection Problem
One of the biggest confounders in the “chronic anaplasmosis” conversation is coinfection. The same blacklegged tick (Ixodes scapularis) that transmits A. phagocytophilum can also carry the Lyme disease bacterium (Borrelia burgdorferi) and the parasite that causes babesiosis (Babesia microti). A single tick bite can deliver more than one pathogen at once.
Coinfection matters because it significantly worsens and prolongs illness. In a well-known study, half of patients coinfected with Lyme disease and babesiosis were still symptomatic at three months, compared to just 4% of patients with Lyme disease alone.9JAMA. Concurrent Lyme Disease and Babesiosis: Evidence for Increased Severity and Duration of Illness Coinfected patients experienced more headaches, fatigue, sweats, chills, and nausea. When someone reports persistent symptoms after what they believe was anaplasmosis, an undiagnosed co-traveling infection, particularly babesiosis, is a real possibility that needs to be ruled out. Babesiosis can smolder for months in people with weakened immune systems, and its symptoms overlap heavily with HGA.
Despite the clinical overlap, the medical literature has not found evidence that A. phagocytophilum and its co-travelers produce a synergistic effect beyond each pathogen’s individual contribution to disease.1PubMed Central. Human granulocytic anaplasmosis In other words, coinfection makes things worse by adding problems, not by multiplying them.
Why Diagnosis Is Harder Than It Sounds
Part of the frustration around anaplasmosis, and one reason patients sometimes feel their illness was never fully identified, is that the available diagnostic tests have real limitations. Blood smear examination looks for characteristic clusters of bacteria inside neutrophils, but these can be easy to miss, especially early or late in the illness. Serology (antibody testing) is best for confirming a past infection rather than catching an active one, since antibodies take time to develop. PCR, which detects bacterial DNA directly, performs best during the first few days of illness and becomes less reliable afterward.
A comparative study found that PCR positivity peaked at about 21% during the first four days of illness but dropped to roughly 12% after day four. Meanwhile, serology worked the opposite way, becoming more reliable during recovery. The two tests agreed poorly with each other, with fewer than one in five seropositive patients also testing PCR-positive.10PubMed Central. Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: importance of infection time course for optimal test utilization This means the timing of the test relative to symptom onset matters enormously, and a single negative result does not reliably rule the infection out.
For patients, the practical consequence is that HGA is often treated empirically, meaning a doctor starts doxycycline based on clinical suspicion and tick-exposure history without waiting for test confirmation. This is standard practice in endemic areas and is actually the recommended approach, because delaying treatment while waiting for lab results can allow the infection to worsen. But it also means that some patients may never get a definitive laboratory-confirmed diagnosis, leaving lingering uncertainty about what they had, which feeds into narratives about chronic or unresolved infection.
Not All Strains Are Created Equal
An underappreciated complication in understanding anaplasmosis is that A. phagocytophilum is not a single uniform organism. Researchers analyzing ticks and human patients found that all strains recovered from sick patients shared the same genetic signature in a key region of their genome, but about a third of strains from ticks had a different sequence, suggesting they may not cause human disease at all.11PubMed Central. A new genetic approach to distinguish strains of Anaplasma phagocytophilum that appear not to cause human disease Broader genetic studies confirm that the species can be divided into variant groups associated with different animal hosts, different levels of pathogenicity, and different geographic niches.12PubMed Central. Distant genetic variants of Anaplasma phagocytophilum from Ixodes ricinus attached to people
This has implications for seroprevalence studies that find high rates of antibodies against A. phagocytophilum in people living in endemic areas. Some of those antibody-positive individuals may have been bitten by ticks carrying strains that could not actually cause illness but still triggered an immune response. It’s another layer of noise that makes interpreting “chronic” exposure or infection claims difficult.
Treatment and What Happens Afterward
Doxycycline remains the first-line treatment and works quickly, with most patients showing improvement within 24 to 48 hours. Lab studies testing multiple strains from different parts of the United States have confirmed that doxycycline, rifampin, and levofloxacin are the most effective antibiotics against A. phagocytophilum in vitro.13PubMed Central. Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States Rifampin is the usual alternative for patients who cannot take doxycycline, such as pregnant women. No antibiotic resistance has been documented in clinical practice.
One concern patients sometimes raise is whether anaplasmosis causes lasting organ damage, particularly to the kidneys, since acute kidney injury is the most common serious complication. A study that followed patients with documented Anaplasma exposure found no increased risk of developing chronic kidney disease afterward, with a risk ratio close to 1.0.14PubMed Central. Risk of Development of Chronic Kidney Disease After Exposure to Borrelia burgdorferi and Anaplasma spp. By contrast, the same study found that patients exposed to B. burgdorferi (the Lyme disease bacterium) did have a moderately elevated risk of chronic kidney disease. This reinforces the point that lingering health problems in people with tick-borne infections may sometimes trace back to a co-pathogen rather than to A. phagocytophilum itself.
A Growing Geographic Footprint
Even if chronic infection in humans remains unproven, the acute disease is becoming more common. Anaplasmosis cases in the United States have been climbing for years, driven in part by the expanding range of the blacklegged tick.15PubMed Central. Geographic variation in the distribution of Anaplasma phagocytophilum variants in host-seeking Ixodes scapularis nymphs and adults in the eastern United States elucidated using next generation sequencing National surveillance data have documented both increasing incidence rates and an expanding geographic range of reported cases over the past two decades.16PubMed Central. Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data
Some regions have seen especially sharp increases. In New York State, the statewide incidence nearly quadrupled between 2010 and 2018. The Capital Region around Albany experienced an eightfold rise, reaching a peak incidence of roughly 49 cases per 100,000 people in 2017.17Emerging Infectious Diseases. Epidemiology and Spatial Emergence of Anaplasmosis, New York, USA, 2010‒2018 As tick habitats move northward and into suburban areas due to changing land use and warming winters, more people are encountering infected ticks. This means more acute cases, more patients with lingering post-infectious symptoms, and inevitably more questions about whether the infection truly went away.
Transmission Beyond Tick Bites
Most people acquire anaplasmosis from a tick that has been attached long enough to transmit the bacterium. Research using mouse models found that transmission could occur in as little as four to eight hours of tick attachment, though the success rate was low at that point (10 to 30%). Once a tick remained attached for 36 hours or more, transmission rates jumped to 70% or higher.18PubMed. Duration of tick attachment necessary for transmission of Anaplasma phagocytophilum by Ixodes scapularis (Acari: Ixodidae) nymphs This makes daily tick checks an effective, if imperfect, prevention strategy.
A less well-known transmission route is through blood products and organ transplants. A review of cases through 2020 identified 132 instances of ehrlichiosis or anaplasmosis in transfusion recipients and transplant patients, including 12 cases linked specifically to transfused blood and 8 that were donor-derived in transplant recipients.19PubMed Central. Ehrlichiosis and Anaplasmosis among Transfusion and Transplant Recipients in the United States Perhaps more unsettling, the standard safety measure of removing white blood cells from donated blood (leukocyte reduction) has not always prevented transmission. Case reports have documented transfusion-transmitted A. phagocytophilum even when all transfused units had undergone leukocyte reduction.20American Journal of Clinical Pathology. Two Cases of Transfusion-Transmitted Anaplasma phagocytophilum Seroprevalence in endemic areas suggests many blood donors have been exposed, so the fact that transfusion cases remain rare implies that some unmeasured factor limits transmission through blood products, but the mechanism is not fully understood.
For transplant recipients, the risk is compounded by the immunosuppressive drugs they take to prevent organ rejection. These patients are less able to fight off the bacterium and more likely to develop severe disease. In that context, a single acute infection can cause prolonged illness not because the bacterium has established chronic residence but because the patient’s artificially suppressed immune system takes much longer to clear it.